These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 30006645)

  • 21. The maculatin peptides from the skin glands of the tree frog Litoria genimaculata: a comparison of the structures and antibacterial activities of maculatin 1.1 and caerin 1.1.
    Rozek T; Waugh RJ; Steinborner ST; Bowie JH; Tyler MJ; Wallace JC
    J Pept Sci; 1998 Apr; 4(2):111-5. PubMed ID: 9620615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Membrane interactions of antimicrobial peptides from Australian frogs.
    Fernandez DI; Gehman JD; Separovic F
    Biochim Biophys Acta; 2009 Aug; 1788(8):1630-8. PubMed ID: 19013126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Membrane binding and perturbation studies of the antimicrobial peptides caerin, citropin, and maculatin.
    Chia CS; Gong Y; Bowie JH; Zuegg J; Cooper MA
    Biopolymers; 2011; 96(2):147-57. PubMed ID: 20564028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigating the importance of the flexible hinge in caerin 1.1: solution structures and activity of two synthetically modified caerin peptides.
    Pukala TL; Brinkworth CS; Carver JA; Bowie JH
    Biochemistry; 2004 Feb; 43(4):937-44. PubMed ID: 14744137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First record of host defence peptides in tadpoles. The magnificent tree frog Litoria splendida.
    Wabnitz PA; Walters H; Tyler MJ; Wallace JC; Bowie JH
    J Pept Res; 1998 Dec; 52(6):477-81. PubMed ID: 9924992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Host-Defense Peptides Caerin 1.1 and 1.9 Stimulate TNF-Alpha-Dependent Apoptotic Signals in Human Cervical Cancer HeLa Cells.
    Ni G; Chen S; Chen M; Wu J; Yang B; Yuan J; Walton SF; Li H; Wei MQ; Wang Y; Chen G; Liu X; Wang T
    Front Cell Dev Biol; 2020; 8():676. PubMed ID: 32850805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radioimmunotherapy of MCF7 breast cancer cell line with 131I-PR81 monoclonal antibody against MUC1: comparison of direct and indirect radioiodination methods.
    Mohammadnejad J; Rasaee MJ; Babaei MH; Paknejad M; Hasan ZM; Salouti M; Gandomkar M; Sadri K
    Hum Antibodies; 2010; 19(1):15-25. PubMed ID: 20555127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design of new truncated derivatives based on direct and reverse mirror repeats of first six residues of Caerin 4 antimicrobial peptide and evaluation of their activity and cytotoxicity.
    Madanchi H; Sardari S; Shajiee H; Taherian S; Ashkar M; Johari B; Shabani AA; Sharafi S
    Chem Biol Drug Des; 2020 Aug; 96(2):801-811. PubMed ID: 32259385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-cancer, immunoregulatory, and antimicrobial activities of the frog skin host-defense peptides pseudhymenochirin-1Pb and pseudhymenochirin-2Pa.
    Mechkarska M; Attoub S; Sulaiman S; Pantic J; Lukic ML; Conlon JM
    Regul Pept; 2014 Nov; 194-195():69-76. PubMed ID: 25447194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The solution structures and activity of caerin 1.1 and caerin 1.4 in aqueous trifluoroethanol and dodecylphosphocholine micelles.
    Wegener KL; Carver JA; Bowie JH
    Biopolymers; 2003 May; 69(1):42-59. PubMed ID: 12717721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New caerin antibacterial peptides from the skin glands of the Australian tree frog Litoria xanthomera. Part 2. Sequence determination using mass spectrometry and associated techniques.
    Steinborner ST; Waugh RJ; Bowie JH; Tyler MJ
    Rapid Commun Mass Spectrom; 1997; 11(9):997-1000. PubMed ID: 9204574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Host-defence caerin 1.1 and 1.9 peptides suppress glioblastoma U87 and U118 cell proliferation through the modulation of mitochondrial respiration and induce the downregulation of CHI3L1.
    Wang Y; Zhong F; Xiao F; Li J; Liu X; Ni G; Wang T; Zhang W
    PLoS One; 2024; 19(6):e0304149. PubMed ID: 38848430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural analysis of calmodulin binding by nNOS inhibitory amphibian peptides.
    Calabrese AN; Bowie JH; Pukala TL
    Biochemistry; 2015 Jan; 54(2):567-76. PubMed ID: 25436860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Backbone cleavages of [M - H](-) anions derived from caerin 1 peptides and some synthetic modifications. Molecular recognition initiating internal cyclisation of Glu23.
    Brinkworth CS; Bowie JH
    Rapid Commun Mass Spectrom; 2002; 16(14):1339-51. PubMed ID: 12112614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7.
    Conlon JM; Galadari S; Raza H; Condamine E
    Chem Biol Drug Des; 2008 Jul; 72(1):58-64. PubMed ID: 18554256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proline-15 creates an amphipathic wedge in maculatin 1.1 peptides that drives lipid membrane disruption.
    Sani MA; Lee TH; Aguilar MI; Separovic F
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt A):2277-89. PubMed ID: 26079051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulinotropic actions of the frog skin host-defense peptide alyteserin-2a: a structure-activity study.
    Ojo OO; Abdel-Wahab YH; Flatt PR; Conlon JM
    Chem Biol Drug Des; 2013 Aug; 82(2):196-204. PubMed ID: 23742240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro and in vivo application of radiolabeled gastrin-releasing peptide receptor ligands in breast cancer.
    Dalm SU; Martens JW; Sieuwerts AM; van Deurzen CH; Koelewijn SJ; de Blois E; Maina T; Nock BA; Brunel L; Fehrentz JA; Martinez J; de Jong M; Melis M
    J Nucl Med; 2015 May; 56(5):752-7. PubMed ID: 25791989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and in vitro and in vivo evaluation of an (18)F-labeled neuropeptide Y analogue for imaging of breast cancer by PET.
    Hofmann S; Maschauer S; Kuwert T; Beck-Sickinger AG; Prante O
    Mol Pharm; 2015 Apr; 12(4):1121-30. PubMed ID: 25748228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new radiopharmaceutical compound (131I-PR81) for radioimmunotherapy of breast cancer: labeling of antibody and its quality control.
    Mohammadnejad J; Rasaee MJ; Babaei MH; Paknejad M; Zahir MH; Salouti M; Rajabi AB; Mazidi M
    Hum Antibodies; 2010; 19(4):79-88. PubMed ID: 21178279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.